ZALEVSKY JONATHAN (Chief R&D Officer) sold 0.9% of their position (199.00 shares) of NEKTAR THERAPEUTICS on the open market
Open‑market sale worth $13.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/21/2026ACC: 0001193125-26-235030
Officer· Chief R&D Officer
Since Oct 2019
-199.00
Net shares
Net seller
$13.0K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
199.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−199.00
Price / share
$65.51
Trade value
$13.04K
% of position
0.9%
5/19/2026
21.17K→20.98K
Total
Net shares
−199.00
Net value
-$13.04K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/19/2026 | S · Sale | −199.00 | $65.51 | $13.04K | 0.9% | 21.17K | 20.98K |
| Total | −199.00 | -$13.04K | ||||||
Derivative Transactions0
No derivative transactions reported